Researchers in San Antonio are set to test antiviral compounds against the Ebola virus amid an outbreak in Central Africa. The effort appears to be part of a broader push to develop new antiviral therapies, with various institutions and organizations involved in related research. However, it is unclear how this specific project may be affected by reports of scrapped studies on vaccines and treatments for future pandemics.